Qing-Quan Zu

Dr. Qing-Quan Zu

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2020 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
JZJin-Xing Zhang
Jin-Xing Zhang
YDYe Ding
Ye Ding
HYHai-Tao Yan
Hai-Tao Yan
CZChun-Gao Zhou
Chun-Gao Zhou
JLJin Liu
Jin Liu
HSHai-Bin Shi
Hai-Bin Shi

1 November 2022 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
GLGuang-Dong Lu
Guang-Dong Lu
HYHai-Tao Yan
Hai-Tao Yan
JZJin-Xing Zhang
Jin-Xing Zhang
SLSheng Liu
Sheng Liu
HSHai-Bin Shi
Hai-Bin Shi
QZQing-Quan Zu
Qing-Quan Zu
Background: To retrospectively evaluate the effectiveness of bronchial artery embolization (BAE) compared with conservative therapy for the treatment of frequent hemoptysis caused by bronchiectasis. Methods: From January 2015 to December 2019, consecutive patients who were admitted due to frequent (more than three times per year) bronchiectasis-related hemoptysis were retrospectively reviewed. Those who were treated with either BAE (n = 69) or conservative therapy (n = 47) were enrolled for analysis. The technical success, clinical success, and complications of the BAE procedure were evaluated. Long-term hemoptysis-free survival rates and clinical success were compared between patients in the BAE group and patients in the conservative group. A Cox proportional hazard regression model was used to identify the predictors of recurrent hemoptysis. Results: The technical success rate was 100% for the BAE procedure, and clinical success was achieved in 92.8% (64 of 69) of cases. No major procedure-related complications occurred, and minor complications were observed in 16 cases (23.2%). The 1-, 2-, and 3-year hemoptysis-free survival rates were 88.3, 71.3, and 66.2%, respectively, for the BAE group and 31.9, 17.6, and 2.5%, respectively, for the conservative treatment group (P < 0.001). Multivariate analysis showed that BAE was a protective factor against recurrent hemoptysis in treated patients. In addition, the presence of cystic bronchiectasis was the only independent risk factor for rebleeding in the whole population and in the BAE group. Conclusions: BAE may provide an effective option for patients with frequent bronchiectasis-related hemoptysis, especially for those without cystic bronchiectasis.

27 September 2023 in Academic Radiology
Verified
Journal Article
Closed access
JZJin-Xing Zhang
Jin-Xing Zhang
HHHong-Jin Hua
Hong-Jin Hua
YCYuan Cheng
Yuan Cheng
SLSheng Liu
Sheng Liu
HSHai-Bin Shi
Hai-Bin Shi
QZQing-Quan Zu
Qing-Quan Zu

31 May 2022 in Annals of Medicine
Verified
Journal Article
Open access
JZJin-Xing Zhang
Jin-Xing Zhang
HYHai-Tao Yan
Hai-Tao Yan
YDYe Ding
Ye Ding
JLJin Liu
Jin Liu
SLSheng Liu
Sheng Liu
HSHai-Bin Shi
Hai-Bin Shi
Skeletal muscle index (SMI) is a promising predictor of clinical outcomes in patients with malignant diseases. As a simpler surrogate of sarcopenia-psoas muscle index (PMI), its predict value for o...

26 April 2024 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
JZJin-Xing Zhang
Jin-Xing Zhang
YCYuan Cheng
Yuan Cheng
JWJuan Wei
Juan Wei
WFWen-Long Fan
Wen-Long Fan
JLJin Liu
Jin Liu
QZQing-Quan Zu
Qing-Quan Zu

5 January 2023 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
KQKai Qiu
Kai Qiu
ZJZhen Yu Jia
Zhen Yu Jia
YCYuezhou Cao
Yuezhou Cao
LZLin-Bo Zhao
Lin-Bo Zhao
QZQing-Quan Zu
Qing-Quan Zu
SLSheng Liu
Sheng Liu
Background Symptomatic intracranial hemorrhage (sICH) is a common and severe complication in patients with acute ischemic stroke (AIS) after treatment with thrombectomy. Objective To explore the ability of admission plasma D-dimer levels to predict sICH after thrombectomy. Methods Between February 2018 and August 2021, consecutive patients with AIS who underwent thrombectomy at our single comprehensive stroke center were retrospectively enrolled. sICH was defined according to the criterion of the Heidelberg Bleeding Classification. Logistic regression analysis was performed to determine the risk factors of sICH. The overall discriminative ability of D-dimer levels in predicting sICH was evaluated by adopting a receiver operating characteristic (ROC) curve. Results Of the 395 enrolled patients, 48 (12.2%) had sICH. Patients with sICH were older (72.9 vs 69.3 years, P=0.037), more often female (62.5% vs 45.5%, P=0.027), had higher D-dimer levels (2.70 vs 0.74 mg/L, P<0.001), higher National Institutes of Health Stroke Scale score (20 vs 15, P<0.001), lower Alberta Stroke Program Early CT Score (8 vs 9, P<0.001), a higher proportion of internal carotid artery occlusions (56.2% vs 30.3%, P<0.001), and less commonly had large-artery atherosclerosis stroke etiology (12.5% vs 32.3%, P=0.010) than patients without sICH. After adjustment for potential confounders, D-dimer levels (adjusted OR=2.45, 95% CI 1.75 to 3.43, P<0.001) remained significantly associated with sICH. Based on the ROC, the D-dimer as a predictor for predicting sICH, presented with a specificity of 86.2%, a negative predictive value of 94.6%, and an area under the curve of 0.774. Conclusion Elevated admission D-dimer levels are an independent predictor of sICH in patients with AIS after thrombectomy.